Maria Jolnerovski

Vandoeuvre-les-nancy, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Sensorineural hearing loss after pediatric cranial radiotherapy: a multicenter analysis of dosimetric and clinical risk factors.

Sensorineural hearing loss after pediatric cranial radiotherapy: a multicenter analysis of dosimetric and clinical risk factors.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: February 02, 2026

SPINAL: study protocol for a multicenter non-inferiority trial evaluating reduce vertebral irradiation volumes in palliative radiotherapy for spinal bone metastases on analgesic efficacy.

SPINAL: study protocol for a multicenter non-inferiority trial evaluating reduce vertebral irradiation volumes in palliative radiotherapy for spinal bone metastases on analgesic efficacy.

Journal: BMC cancer

Published: January 23, 2026

How to improve the implementation of new radiotherapy guidelines? Interests and limits of a national training workshop.

How to improve the implementation of new radiotherapy guidelines? Interests and limits of a national training workshop.

Journal: The British journal of radiology

Published: December 22, 2025

Rib Ewing Sarcomas in Children and Young Adults: A Large National Retrospective Series.

Rib Ewing Sarcomas in Children and Young Adults: A Large National Retrospective Series.

Journal: Pediatric blood & cancer

Published: February 28, 2025

Role of radiotherapy in the management of anal canal cancer: Recommendations of the Société française de radiothérapie oncologique.

Role of radiotherapy in the management of anal canal cancer: Recommendations of the Société française de radiothérapie oncologique.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: February 03, 2025

Correction: Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.

Correction: Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.

Journal: Radiation oncology (London, England)

Published: January 23, 2025

Local control and recurrence patterns after stereotactic irradiation delivered in more than 4 fractions for hepatocellular carcinomas and liver metastases: a retrospective study.

Local control and recurrence patterns after stereotactic irradiation delivered in more than 4 fractions for hepatocellular carcinomas and liver metastases: a retrospective study.

Journal: Radiation oncology (London, England)

Published: November 06, 2024

Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.

Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.

Journal: Radiation oncology (London, England)

Published: June 19, 2024

Is hypofractionated radiotherapy used to treat soft tissue sarcomas? Assessment of practices using the NETSARC network.

Is hypofractionated radiotherapy used to treat soft tissue sarcomas? Assessment of practices using the NETSARC network.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: April 10, 2024

Post-operative flank irradiation using conformal versus highly conformal radiotherapy techniques for paediatric renal tumours: Results from the French registry PediaRT.

Post-operative flank irradiation using conformal versus highly conformal radiotherapy techniques for paediatric renal tumours: Results from the French registry PediaRT.

Journal: Pediatric blood & cancer

Published: April 03, 2023

Treatment related factors associated with the risk of breast radio-induced-sarcoma.

Treatment related factors associated with the risk of breast radio-induced-sarcoma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: August 06, 2021

Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol.

Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol.

Journal: BMJ open

Published: September 24, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026